Wonbiogen

원바이오젠 · 307280

Health Care Pharmaceuticals · KOSDAQ

Small-cap

Market cap US$30.9M (₩42.7B)

Overview

Wonbiogen makes wound dressings, adhesive medical coverings that keep injuries moist to help them heal faster, with its core products being foam dressings and hydrocolloid dressings.

It supplies these products to domestic pharmaceutical companies under an ODM (own-design, manufacturer-branded) arrangement and through its own branded distribution network, reaching hospitals as well as pharmacies and general retail channels. Listed on KOSDAQ, Korea's tech and small-cap board, the company's product range is concentrated in these two wound-dressing formats.

Summary is AI-generated and may contain errors · figures from DART filings

Financials

Source: DART · FY ending Dec · latest FY2025

Revenue · FY2025

US$25.5M

▲ +15.8% YoY

Operating profit · FY2025

US$5.7M

▲ +23.7% YoY

Net income · FY2025

US$4.7M

▲ +21.0% YoY

Revenue, operating profit and net income by fiscal year (USD; KRW in parentheses).
Metric	FY2023	FY2024	FY2025
Revenue	US$21.5M(₩29.6B)	US$22.1M(₩30.4B)	US$25.5M(₩35.2B)
Operating profit	US$5.2M(₩7.1B)	US$4.6M(₩6.4B)	US$5.7M(₩7.9B)
Net income	US$4.3M(₩6B)	US$3.9M(₩5.3B)	US$4.7M(₩6.5B)

Revenue

FY2023US$21.5M
FY2024US$22.1M
FY2025US$25.5M

Operating profit

FY2023US$5.2M
FY2024US$4.6M
FY2025US$5.7M

Net income

FY2023US$4.3M
FY2024US$3.9M
FY2025US$4.7M

Key ratios (FY2025)

ROE

15.2%

Debt/Eq

11.7%

Op. margin

22.5%

Net margin

18.3%

Rev. YoY

▲ +15.8%

Price charts coming soon

Interactive price history isn't here yet. Would you use it?